vaccine brands

EACH DOSE OF 0.5 ML CONTAINS: MENINGOCOCCAL A POLYSACCHARIDE 10 MCG TT (CARRIER PROTEIN) 10 TO 33 MCG

5MCG

MOSQUIRIX 0.5 ML CONTAINS 25 MICROGRAM OF RTSS 25 MICROGRAM OF MPL AND 25 MICROGRAM OF QS-21

EID 50 > 10 POWER 6/DOSES PER 0.3ML

1 DOSE

Injection

EACH DOSE CONTAINS ATLEAST 3.0 LOG TCID50 CHICKEN ANAEMIA VACCINE VIRUS

AFTER RECONSTITUTION ONE DOSE (0.5 ML) CONTAINS: DIPHTHERIA TOXOID ......... 30 IU TETANUS TOXOID ........ 40 IU BORDETELLA PERTUSSIS ANTIGENS: PERTUSSIS TOXOID ........25 MICROGRAMS FILAMENTOUS HAEMAGGLUTININ ...........25 MICROGRAMS TYPE

EACH DOSE OF 2 DROPS (0.1ML) CONTAINS POLIO VIRUS (SABIN) OPV SABIN BIVALENT STRAIN TYPE I AND III VIRUSES: NOT LESS THAN 6.21 LGCCID50/DOSE OPV SABIN STRAIN TYPE I VIRUSES: NOT LESS THAN 6.0 LGCCID50/DOSE OPV SABIN STRAIN TYPE III VIRUSES: NOT LESS THAN

TYPE 1_>700 DU/ML, TYPE 2_>500 DU/ML, TYPE 3_>700DU/ML

MEASLES > 10^3.0 CCID503 MUMPS > 10^4.4 CCID503 RUBELLA > 10^3.0 CCID503 AND VARICELLA > 10^3.3 PFU RESPECTIVELY

MEASLES > 10^3.0 CCID503 MUMPS > 10^3.7 CCID503 AND RUBELLA > 10^3.0 CCID503 RESPECTIVELY

Injection

BURSAL DISEASE VIRUS-BEARING FLUIDS >105.2 TCID50 PER DOSE AT RELEASE (LUKERT STRAIN) NEWCASTLE DISEASE VIRUS-BEARING FLUIDS >107.7 EID50 PER DOSE AT RELEASE (KIMBER STRAIN) BRONCHITIS VIRUS-BEARING FLUIDS >106.9 EID50 PER DOSE AT RELEASE (M-4

EACH DOSE OF 1 ML CONTAINS: POTENCY OF RABIES ANTIGEN 2.5 I.U. ADSORBED ONTO ALUMINIUM PHOSPHATE. AL+++ NOT MORE THAN 1.25 MG PRESERVATIVE: THIOMERSAL 0.01 %

INACTIVATED AND CONCENTRATED NEWCASTLE DISEASE VIRUS, B1 TYPE MIN 108.8 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS TYPE, STRAIN M-41 MIN 106.1 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS T

10 MCG / 0.5 ML

10 MCG / 0.5 ML

> 10^6.0 CCID50

Oral Suspension

EACH DOSE OF 2.5 ML CONTAINS LIVE ATTENUATED BOVINE HUMAN REASSORTANT STRAINS OF ROTAVIRUS SEROTYPES G1, G2, G3, G4 AND G9 105.6 FFU OF EACH SEROTYPE GROWN ON VERO CELLS

EACH DOSE OF 2.5 ML CONTAINS: LIVE ATTENUATED BOVINE HUMAN ROTAVIRUS REASSORTANT SEROTYPE

EACH ORAL DOSE OF 1.5ML CONTAINS:V.CHOLERAE O1 INABA EL TOR STRAIN PHIL 6973 FORMALDEHYDE KILLED -600 ELISA UNITS (EU) OF LIPOPOLYSACCHARIDE (LPS) V.CHOLERAE O1 OGAWA CLASSICAL STRAIN CAIRO 50 HEAT KILLED -300 EU OF LPS V.CHOLERAE O1 OGAWA CLASSICAL S

RDNA HEPATITIS B SURFACE ANTIGEN PURIFIED (HBSAG) 20 MCG/1 ML

PROTECTIVE ACTIVITY OF ANTI RABIES ANTIGEN 2.5 IU

EACH SINGLE 0.5 ML HUMAN DOSE CONTAINS TETANUS TOXOID 5 LF ( 40 IU)

ONE DOSE (0.5 ML) CONTAINS: DIPHTHERIA TOXOID 30 IU TETANUS TOXOID 40 IU BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25 MICROGRAMS) FILAMENTOUS HAEMAGGLUTININ 25 MICROGRAMS TYPE 1 POLIOMYELITIS VIRUS (INACTIVATED) 40 DU TYPE 2 POLIOMYEL

CLSTRIDIUM PERFRINGENS ANATOXIN (TYPES BC & D) CLOSTRIDIUM SEPTICUM & CLOSTRIDIUM NOVYI ANATOXIN IN ADEQUATE LEVELS TO INDUCE 10 IU OF TYPE B CLOSTRDIUM PERFRINGENS BETA-ANTITOXIN/ML OF SERUM 10IU OF TYPE C CLOSTRIDIUM PERFRINGENS BETA-ANTITOXIN/ML OF

>30IU >60IU: >4IU 10MCGS RESPECTIVELY

>720 EU & 20 MCG/ML RESPECTIVELY

>360 EU & 10 MCG / 0.5 ML RESPECTIVELY

25 G / 0.5 ML

25 MG OF VI AG/ ML

>103.3 PFUS / 0.5 ML

ACTIVE PER 0.01ML DOSE: AVIAN ENCEPHALOMYELITIS CALNEK STRAIN …………………MIN 102.7 EID50 PER DOSE THROUGH EXPIRATION FOWL POX-MYCOPLASMA GALLISEPTICUM CUTTER STRAIN…………………………………….MIN 102.7 TCID50 PER DOSE THROUGH EXPIRATION